M. Castiglione

发表

The duration of a life of quality should become the focus of "quality-of-life" studies.

R. Gelber, A. Goldhirsch, M. Castiglione, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The enigma of young age.

M. Castiglione, S. Aebi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Present and future projects of the international breast cancer study group

J. Forbes, F. Cavalli, R. Gelber, 1994, Cancer.

Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, S. Aebi, M. Castiglione, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, S. Aebi, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

Robert B Livingston, Dongsheng Tu, Jeffrey S Abrams, 2005, Journal of the National Cancer Institute.

Preventive therapy for breast cancer: a consensus statement.

Jack Cuzick, Anthony Howell, J. Cuzick, 2011, The Lancet. Oncology.

Adjuvant Endocrine Therapy

M. Castiglione, M. Rabaglio, 2018 .

Adjuvant Therapy for Node-Negative Breast Cancer

I. Tannock, C. Redmond, R. Gelber, 1989 .

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Terry L. Smith, R. Collins, L. Holmberg, 1998, Lancet.

Integration of Quality-of-Life Issues into Clinical Trials of Breast Cancer

R. Gelber, P. Glasziou, A. Goldhirsch, 1989 .

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Ivanov, Harris, R. Collins, 2005, The Lancet.

Hormonal therapy for oestrogen receptor-negative breast cancer is associated with higher disease-specific mortality.

G. Vlastos, H. Verkooijen, P. Chappuis, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.

E. Perez, M. Piccart, S. Martino, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy of letrozole extended adjuvant therapy according to estrogen receptor and progesterone receptor status of the primary tumor: National Cancer Institute of Canada Clinical Trials Group MA.17.

E. Perez, M. Piccart, S. Martino, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17.

E. Perez, M. Piccart, S. Martino, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

clinical practice guidelines Endometrial cancer : ESMO Clinical Practice Guidelines for diagnosis , treatment and follow-up

M. Castiglione, G. Plataniotis, 2010 .

Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, G. Plataniotis, M. Castiglione, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

C. Haie-meder, M. Castiglione, P. Morice, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

The impact of adding low-dose leucovorin to monthly 5-fluorouracil in advanced colorectal carcinoma: results of a phase III trial. Swiss Group for Clinical Cancer Research (SAKK).

R. Herrmann, A. Goldhirsch, M. Castiglione, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, F. Cardoso, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

First repeated bone scan in the observation of patients with operable breast cancer.

R. Gelber, A. Goldhirsch, M. Castiglione, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87

M. Castiglione, C. Maurer, U. Metzger, 2015, Langenbeck's Archives of Surgery.

Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, M. Baekelandt, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, R. Verheijen, N. Reed, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II trial of Nimustine (ACNU; 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride) in patients with small cell carcinoma of the lung after failure on combination chemotherapy

F. Cavalli, M. Castiglione, C. Ludwig, 2004, Investigational New Drugs.

Adjuvant intraportal chemotherapy for colorectal cancer

A. Goldhirsch, M. Castiglione, U. Metzger, 1995, The Lancet.

Clinical recommendations of European Society for Medical Oncology for diagnosis, treatment and follow-up of selected cancer in women

C. Haie-meder, M. Castiglione, N. Pavlidis, 2008 .

Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)

R. Gelber, A. Goldhirsch, M. Castiglione, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)

F. Cavalli, A. Goldhirsch, M. Castiglione, 1997, European journal of cancer.

[Adjuvant treatment of breast cancer].

A. Goldhirsch, M. Castiglione, 1988, Gynäkologisch-Geburtshilfliche Rundschau.

Cyclooxygenase-2 (COX-2) a new prognostic and predictive factor for ovarian cancer? Are all the criteria fulfilled?

M. Castiglione, M. Nasi, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, N. Pavlidis, G. Pentheroudakis, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial

A. Giobbie-Hurder, P. Neven, R. Gelber, 2020, Breast Cancer Research and Treatment.

IBCSG's reply

R. Gelber, A. Goldhirsch, M. Castiglione, 1993, The Lancet.

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V.

Per Karlsson, Zhuoxin Sun, J. Forbes, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cervical cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

C. Haie-meder, M. Castiglione, P. Morice, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

The Perceived Adjustment to Chronic Illness Scale (PACIS): a global indicator of coping for operable breast cancer patients in clinical trials

A. Goldhirsch, M. Castiglione, C. Hürny, 1993, Supportive Care in Cancer.

Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, M. Baekelandt, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Prevalence of the rhesus‐negative phenotype in caucasian patients with small‐cell lung cancer (SCLC)

M. Castiglione, M. Fey, M. Lind, 1992, International journal of cancer.

Association between immunity and prognostic factors in early stage breast cancer patients before adjuvant treatment

R. Herrmann, A. Goldhirsch, M. Castiglione, 2000, Breast Cancer Research and Treatment.

A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group).

R. Gelber, A. Goldhirsch, M. Castiglione, 1992, Journal of the National Cancer Institute. Monographs.

Interaction of tamoxifen with concurrent cytotoxic adjuvant treatment affects lymphocytes and lymphocyte subsets counts in breast cancer patients

A. Goldhirsch, M. Castiglione, C. Hürny, 1999, Supportive Care in Cancer.

Adjuvant Breast Cancer Treatment : Evolution or Revolution ?

M. Piccart, A. Goldhirsch, M. Castiglione, 2005 .

clinical recommendations Cancer , fertility and pregnancy : ESMO Clinical Recommendations for diagnosis , treatment and follow-up

M. Castiglione, N. Pavlidis, G. Pentheroudakis, 2009 .

Original article Docetaxel (Taxotere®)-cisplatin (TC): An effective drug combination in gastric carcinoma

F. Cavalli, M. Castiglione, M. Aapro, 2005 .

Breast Cancer in Younger Women

M. Castiglione, M. Rabaglio, 2010 .

Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).

F. Cavalli, R. Gelber, A. Goldhirsch, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

C. Haie-meder, M. Castiglione, P. Morice, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

BRCA in breast cancer: ESMO Clinical Practice Guidelines.

M. Castiglione, O. Díez, I. Rubio, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

BRCA in breast cancer: ESMO clinical recommendations.

M. Castiglione, O. Díez, J. Balmaña, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of breast cancer in elderly patients

R. Gelber, R. Gelman, A. Goldhirsch, 1990, The Lancet.

Concordance between Core Needle Biopsy and Surgical Excision Specimens for Tumour Hormone Receptor Profiling According to the 2011 St. Gallen Classification, in Clinical Practice

M. Castiglione, J. Tille, P. Petignat, 2013, The breast journal.

Reporting Results from Adjuvant Therapy Trials with Special Emphasis on Quality-of-Life Findings

R. Gelber, A. Goldhirsch, M. Castiglione, 1992 .

Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.

M. Zelen, R. Gelber, A. Goldhirsch, 1989, The New England journal of medicine.

Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer : Results of the International Breast Cancer Study Group ( IBCSG ) Trial

F. Cavalli, A. Goldhirsch, M. Castiglione, 2005 .

Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–

J. Forbes, R. Gelber, A. Goldhirsch, 2001 .

Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

F. Cavalli, A. Goldhirsch, M. Castiglione, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer.

M. Castiglione, M. Borner, M. Bacchi, 1996, European journal of cancer.

First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research.

F. Cavalli, A. Goldhirsch, M. Castiglione, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.

E. Perez, M. Piccart, S. Martino, 2004, The New England journal of medicine.

A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer

E. Perez, M. Piccart, S. Martino, 2003 .

Non-epithelial ovarian cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, N. Colombo, M. Peiretti, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

F. Cavalli, R. Herrmann, A. Goldhirsch, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

P. Lønning, J. Forbes, R. Coombes, 2007, The Lancet.

Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, S. Aebi, T. Davidson, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer.

J L Pater, M. Piccart, S. Martino, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.

F. Cavalli, R. Gelber, A. Goldhirsch, 1998, European journal of cancer.

Effectiveness of adjuvant chemotherapy in combination with tamoxifen for node-positive postmenopausal breast cancer patients.

M. Zelen, R. Gelber, B. Gusterson, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Original article: Sequential estrogen receptor determinations from primary breast cancer and at relapse: Prognostic and therapeutic relevance

F. Cavalli, A. Goldhirsch, M. Castiglione, 1992 .

Ifosfamide by continuous infusion to prevent encephalopathy

M. Castiglione, G. Martinelli, K. Brunner, 1990, The Lancet.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

L. Fallowfield, M. Castiglione, F. Cardoso, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, C. Sessa, N. Colombo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

L. Fallowfield, M. Castiglione, F. Cardoso, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Life quality assessment of breast cancer patients receiving adjuvant therapy using incomplete data.

M. Castiglione, P. Busch, P. Schwendener, 1993, Health economics.

New criteria for selecting elderly patients for breast cancer adjuvant treatment studies.

A. Goldhirsch, M. Castiglione, M. Colleoni, 2007, The oncologist.

Breast cancer management and outcome according to surgeon's affiliation: a population-based comparison adjusted for patient's selection bias.

M. Castiglione, G. Fioretta, E. Rapiti, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of obesity on diagnosis and treatment of breast cancer

G. Vlastos, H. Verkooijen, P. Chappuis, 2010, Breast Cancer Research and Treatment.

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.

R. Gelber, A. Goldhirsch, M. Castiglione, 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Effect of systemic adjuvant treatment on first sites of breast cancer relapse

G Marini, M. Tattersall, J. Forbes, 1994, The Lancet.

Isolated Tumor Cells in Sentinel Lymph Nodes of Invasive Breast Cancer: Cell Displacement or Metastasis?

M. Castiglione, J. Tille, P. Loubeyre, 2014, The breast journal.

Risk of second breast cancer according to estrogen receptor status and family history

G. Vlastos, H. Verkooijen, P. Chappuis, 2011, Breast Cancer Research and Treatment.

Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up.

M. Castiglione, N. Pavlidis, G. Pentheroudakis, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.

R. Gelber, A. Goldhirsch, M. Castiglione, 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.

R. Gelber, A. Goldhirsch, M. Castiglione, 1992, European journal of cancer.

The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.

R. Gelber, A. Goldhirsch, M. Castiglione, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.

R. Gelber, A. Goldhirsch, M. Castiglione, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Duration of letrozole treatment and outcomes in the placebo-controlled NCIC CTG MA.17 extended adjuvant therapy trial

E. Perez, M. Piccart, S. Martino, 2006, Breast Cancer Research and Treatment.

Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.

R. Gelber, A. Goldhirsch, M. Castiglione, 2016, International journal of radiation oncology, biology, physics.

The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.

F. Cavalli, A. Goldhirsch, M. Castiglione, 1995, Israel journal of medical sciences.

Adjuvant therapy of breast cancer

R. Gelber, A. Goldhirsch, M. Castiglione, 1991 .

Adjuvant Chemotherapy in Premenopausal Breast Cancer Patients is Effective by Means Other than Ovarian Function Suppression

R. Gelber, A. Goldhirsch, M. Castiglione, 1990 .

Primary breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

V. Kataja, M. Castiglione, V Kataja, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Timing breast cancer surgery

J. Forbes, R. Gelber, R. Blamey, 1991, The Lancet.

Prognostic value of Helix pomatia in breast cancer. International (Ludwig) Breast Cancer Study Group.

R. Gelber, M. Castiglione, H. Jayatilake, 1993, British Journal of Cancer.

Adjuvant chemotherapy in operable breast cancer: cyclophosphamide, methotrexate, and fluorouracil versus chlorambucil, methotrexate, and fluorouracil--11-year results of Swiss Group for Clinical Cancer Research trial SAKK 27/82.

F. Cavalli, M. Castiglione, H. Senn, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The cognitive-spiritual dimension--an important addition to the assessment of quality of life: validation of a questionnaire (SELT-M) in patients with advanced cancer.

M. Castiglione, C. Hürny, P. Heusser, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Cisplatin, doxorubicin and etoposide (PAV) in advanced gastric carcinoma: the SAKK experience. Swiss Group for Clinical Cancer Research (SAKK).

R. Herrmann, M. Castiglione, M. Borner, 1998, European Journal of Cancer.

Breast cancer screening by mammography : International evidence and the situation in Switzerland

D. Schopper, M. Castiglione, J. Bulliard, 2007 .

A Phase II study of oral idarubicin as a treatment for metastatic hormone‐refractory prostate carcinoma with special focus on prostate specific antigen doubling time

M. Castiglione, H. Schmid, R. Morant, 1997 .

A phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Swiss Group for Clinical Cancer Research, Berne, Switzerland.

M. Castiglione, J. Bernhard, H. Schmid, 1997, Cancer.

Considerable side effects of chemoembolization for colorectal carcinoma metastatic to the liver.

M. Castiglione, M. Borner, L. Blumgart, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, C. Sessa, N. Colombo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

M. Castiglione, C. Sessa, N. Colombo, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Taxotere-cisplatin (TC) in advanced gastric carcinoma (AGC): A promising drug combination

F. Cavalli, R. Herrmann, A. Goldhirsch, 1997 .

Adjuvant Therapy for Primary Breast Cancer in a Female Patient Affected by Autoimmune Liver Disease: Does it Cure Breast Cancer and Primary Biliary Cirrhosis?

M. Castiglione, D. Crivellari, S. Monfardini, 1992, Tumori.